José Luis Vizmanos Pérez-rekin lankidetzan egindako argitalpenak (9)

2024

  1. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab

    Drug Delivery and Translational Research, Vol. 14, Núm. 5, pp. 1189-1205

2021

  1. Caenorhabditis elegans as a model under hyperglicemic conditions to evaluate insulin-loaded nanoparticles

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 202-204

  2. In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions

    Acta Pharmaceutica Sinica B, Vol. 11, Núm. 4, pp. 989-1002

  3. Zein-based nanocarriers for the oral delivery of insulin. In vivo evaluation in Caenorhabditis elegans

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 647-658

2020

  1. Improvement of antioxidant activity of oregano (Origanum vulgare L.) with an oral pharmaceutical form

    Biomedicine and Pharmacotherapy, Vol. 129

2019

  1. A simple and a reliable method to quantify antioxidant activity in vivo

    Antioxidants, Vol. 8, Núm. 5

  2. Broccoli extract improves high fat diet-induced obesity, hepatic steatosis and glucose intolerance in Wistar rats

    Journal of Functional Foods, Vol. 59, pp. 319-328

  3. Low doses of cocoa extract supplementation ameliorate diet-induced obesity and insulin resistance in rats

    Food and Function, Vol. 10, Núm. 8, pp. 4811-4822

2018

  1. Cyclodextrin-grafted poly(anhydride) nanoparticles for oral glibenclamide administration. In vivo evaluation using C. elegans

    International Journal of Pharmaceutics, Vol. 547, Núm. 1-2, pp. 97-105